Sun Pharmaceutical Industries has agreed to acquire US-based Organon & Co. for $11.75 billion in an all-cash transaction, marking the largest overseas acquisition by an Indian pharma firm. The deal ...

India's dealmaking landscape in the April-June quarter was dominated by a handful of blockbuster transactions, with Sun ...

India’s largest pharmaceutical company will acquire Jersey City-based drugmaker Organon & Co. in an all-cash deal valued at about $11.75 billion. Sun Pharma will buy Organon for $14 a share. The price ...

New Delhi: Sun Pharma, India's largest drugmaker, has announced its biggest overseas acquisition yet. The company will buy US-based Organon & Co for $11.8 billion (around Rs 98,000 crore) in an ...

Sun Pharma's $11.75 billion Organon acquisition was much bigger than a typical pharma deal. Once people looked past the headline, the story became surprisingly interesting. The acquisition involved ...

India's Sun Pharmaceutical Industries has agreed to acquire U.S.-listed healthcare company Organon in a deal valuing the company at $11.75 billion, putting the Indian drugmaker on track to become one ...

April 26 (Reuters) - Sun Pharmaceutical Industries will buy U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion including debt, for the ‌largest overseas acquisition by an ...

After a tumultuous run on its own as a public company following its 2021 spinoff from Merck, Organon appears likely to be acquired by Sun Pharmaceutical Industries for $14 per share in cash. The ...

Organon’s portfolio includes more than 70 products across women’s health and general medicines, including biosimilars. The transaction has been approved by the Boards of Directors of both Sun Pharma ...

Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of Organon’s women’s health products, legacy ...

India’s Sun Pharmaceutical Industries 5247150.24%increase; green up pointing triangle has agreed to acquire U.S. drugmaker Organon OGN-0.15%decrease; red down pointing triangle in an $11.75 billion ...